YIMMUGO® Now Available in the U.S.: Kedrion Biopharma Commercializes a New Ig Therapy for PI

Retrieved on: 2025-10-09 16:26:50

Tags for this article:

Click the tags to see associated articles and topics

YIMMUGO® Now Available in the U.S.: Kedrion Biopharma Commercializes a New Ig Therapy for PI. View article details on hiswai:

Excerpt

PRNewswire/ -- Kedrion Biopharma is proud to announce the U.S. availability of YIMMUGO (Immune Globulin Intravenous, Human-dira, 10%), ...

Article found on: www.prnewswire.com